- Home
- FDMT vs GROY Comparison
FDMT vs GROY Comparison
Compare FDMT & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | GROY |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 618.6M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FDMT | GROY |
|---|---|---|
| Price | $10.07 | $2.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $31.71 | $5.90 |
| AVG Volume (30 Days) | 868.4K | ★ 1.7M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | $145.80 |
| Revenue Next Year | $70.28 | $60.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $4.27 | $2.45 |
| 52 Week High | $14.00 | $5.45 |
Technical Indicators
Market Signals| Indicator | FDMT | GROY |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 41.16 |
| Support Level | $9.71 | $2.45 |
| Resistance Level | $10.50 | $3.14 |
| Average True Range (ATR) | 0.79 | 0.08 |
| MACD | -0.30 | 0.02 |
| Stochastic Oscillator | 9.04 | 41.01 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About GROY Gold Royalty Corp.
Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.